Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)
Previous Close
$4.76
52W Range
$2.58 - $44.40
50D Avg
$4.49
200D Avg
$6.27
Market Cap
$21.58M
Avg Vol (3M)
$41.50K
Beta
1.14
Div Yield
-
SHPH Company Profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.